GROWTH EQUITY OPPORTUNITIES FUND IV (ADDEX THERAPEUTICS) - SCHEDULE 13D/A2

Company

Addex Therapeutics Ltd.

Filed

August 23, 2022

Accession Number

0001072613-22-000523